Karilyn T M Larkin

20PUBLICATIONS
163CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)HaematologyCardiology (incl. cardiovascular diseases)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 14, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

|Jul 13, 2026
Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study.

|Feb 24, 2026
Successful engraftment in myeloablative transplant with cadaveric bone marrow after sudden unavailability of living donor.

Sumithira Vasu, Sarah Wall, Karilyn Larkin

|Feb 23, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

Sumithira Vasu, Nathan Denlinger, No-Joon Song

|Nov 19, 2025
Successful engraftment in myeloablative transplant with cadaveric bone marrow after sudden unavailability of living donor.

Sumithira Vasu, Sarah Wall, Karilyn Larkin

|Jun 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.

Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan

Pageof 4

Frequent Collaborators

4 joint publications

Monzr M Al Malki

4 joint publications

James S Blachly

4 joint publications

Marcos J de Lima

4 joint publications

Alice S Mims